Clinical Trials Insight: 700032082
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2008
At a glance
- Drugs ARI 2243 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Arisaph Pharmaceuticals
- 01 Apr 2008 New trial record.
- 11 Mar 2008 The trial is expected to be initiated in the first half of 2008.
- 11 Mar 2008 US FDA accepted Investigational New Drug application.